Back to Trades
KARBE FRANK
Chief Financial OfficerCIK 0001276700
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
KARBE FRANK, Chief Financial Officer, has filed 1 SEC report (2026), all concentrated in Cidara Therapeutics, Inc. (CDTX), totaling $4.0M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jan 7 | CDTX Cidara Therapeutics, Inc. | KARBE FRANK | Chief Financial Officer | Disposed | $4.0M |
1 filing